摘要
目的 研究不同剂量罗库溴铵在腹腔镜袖套状胃大部切除术的女性病态肥胖患者中的效用。方法 48名病态肥胖女性患者（体重指数>40 kg·m-2，行腹腔镜袖套状胃大部切除术，随机分成3组，分别用罗库溴铵0.6 mg·kg-1，Ⅰ组16例，根据实际体重；Ⅱ组16例，根据理想体重；Ⅲ组16例，根据理想体重加上20%超标体重。应用丙泊酚和瑞芬太尼诱导后，注射罗库溴铵，记录罗库溴铵的起效时间﹑T1恢复到25%的时间和恢复指数。结果 罗库溴铵的起效时间在Ⅰ组较Ⅲ组和Ⅱ组明显缩短 (P<0.05；3组的插管评分差异无显著性意义；T1恢复到25%的时间，Ⅰ组较Ⅱ组和Ⅲ组明显延长 (P<0.05，Ⅱ组与Ⅲ组相比，明显缩短 (P<0.05。恢复指数在Ⅰ组与Ⅱ组及Ⅲ组相比，有延长趋势 (P<0.05。结论 病态肥胖患者，在丙泊酚和瑞芬太尼诱导和维持下，罗库溴铵根据理想体重给药，可以获得优质的气管插管条件，且作用时效明显缩短。
Abstract
ABSTRACT: OBJECTIVE To compare the onset time, conditions for tracheal intubation, and duration of action of rocuronium in morbidly obese patients undergoing laparoscopic sleeve gastrectomy. METHODS Forty-eight mobidly obese patients scheduled for laparoscopic sleeve gastrectomy under propofol-remifentanil anesthesia were randomized into 3 groups. The patients received rocuronium (0.6 mg·kg-1 based on real body weight ( group Ⅰ, n=16, ideal body weight ( group Ⅱ, n=16, or ideal body weight plus 20% of excess weight (group Ⅲ, n=16. Propofol and remifentanil were administered both according to real body weight. RESULTS The median onset time was 52.1, 88.5, and 85.1 s in groupⅠ, Ⅱ, and Ⅲ, respectively (P<0.05 for comparison of the groupⅠand Ⅱ.The median durations of action were 51.6, 23.6, and 29.8 min in group Ⅰ, Ⅱ, and Ⅲ, respectively (P<0.05 for comparison of group Ⅰand Ⅱ, and group Ⅱand Ⅲ. There were no significant differences in intubation conditions 90 s after administration of rocuronium. CONCLUSION In mobidly obese patients undergoing laparoscopic sleeve gastrectomy, rocuronium dosed according to ideal body weight provided a shorter duration of action without significantly prolonged onset time or poor conditions for tracheal intubation.
关键词
病态肥胖 /
罗库溴铵 /
腹腔镜下袖套状胃大部切除术
{{custom_keyword}} /
Key words
morbidly obese patients /
rocuronium /
laparoscopic sleeve gastrectomy
{{custom_keyword}} /
葛云芬 严美娟.
病态肥胖患者的罗库溴铵使用剂量[J]. 中国药学杂志, 2011, 46(12): 960-962
GE Yun-fen;YN Mei-jun.
Nuromuscular Pharmacodynamics of Rocuronium in Morbidly Obese Patients[J]. Chinese Pharmaceutical Journal, 2011, 46(12): 960-962
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] LEYKINY， PELLIS T， LUCCA M，et al. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients[J]. Anesth Analg，2004， 99(4：1086-1089.
[2] COOPER R， MIRAKHUR R K， CLARKE R S， et al. Comparison of intubating conditions after administration of Org 9246 (rocuronium and suxamethonium[J]. Br J Anaesth， 1992， 69(3：269-273.
[3] DUVALDESTIN P. Residual neuromuscular blockade and upper airway muscles[J]. Anesthesiology， 2010， 112(1：246-247.
[4] ADAMUS M， GABRHELIK T， MAREK O. Influence of gender on the course of neuromuscular block following a single bolus dose of cisatracurium or rocuronium[J]. Eur J Anaesthesiol， 2008， 25(7：589-595.
[5] HANNA S F， AHMAD F， PAPPAS A L， et al. The effect of propofol/remifentanil rapid-induction technique without muscle relaxants on intraocular pressure[J]. J Clin Anesth， 2010， 22(6：437-442.
[6] MEYHOFF C S， LUND J， JENSTRUP M T，et al. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight[J]. Anesth Analg， 2009， 109(3：787-792.
[7] VEIGA-RUIZ G， DOMíNGUEZ N， OROZCO J， et al. Efficacy of sugammadex in the reversal of neuromuscular blockade induced by rocuronium in long-duration surgery： under inhaled vs. intravenous anesthesia[J]. Rev Esp Anestesiol Reanim，2009， 56(6：349-354.
[8] VAN KRALINGEN S， DIEPSTRATEN J， VAN DE GARDE E M，et al. Comparative evaluation of propofol 350 and 200 mg for induction of anaesthesia in morbidly obese patients： a randomized double-blind pilot study[J]. Eur J Anaesthesiol， 2010， 27(6：572-574.
[9] SHIMURA R， TATSUMI K， NAKAMURA A， et al. Fat accumulation， leptin， and hypercapnia in obstructive sleep apnea-hypopnea syndrome[J]. Chest， 2005， 127(2：543-549.
[10] LU I C， TSAI C J， WU C W， et al. A comparative study between 1 and 2 effective doses of rocuronium for intraoperative neuromonitoring during thyroid surgery[J]. Surgery， 2011， 149(4：543-548.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
PDF(438 KB)
